Market Cap 1.47B
Revenue (ttm) 605.22M
Net Income (ttm) -168.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.86%
Debt to Equity Ratio 0.57
Volume 1,714,300
Avg Vol 1,625,282
Day's Range N/A - N/A
Shares Out 111.98M
Stochastic %K 38%
Beta 0.73
Analysts Strong Sell
Price Target $25.21

Company Profile

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic ca...

Industry: Medical Devices
Sector: Healthcare
Address:
Neuhofstrasse 21, Baar, Switzerland
Kyle7776
Kyle7776 Jan. 4 at 12:10 PM
$NVCR run to 20 or more with positive panova 4 data?
0 · Reply
GordonGecko_was_THE_MAN
GordonGecko_was_THE_MAN Jan. 3 at 8:35 PM
$NVCR (1/n) Science geeks: for a long time skeptics have asked exactly how TTFs work? Most who follow the story understand alternating fields re-orient the polar molecules required for the cell division, thus preventing proper division. However, we now have lots of data saying TTFs + IO is synergistic, that TTFs turn cold tumors hot. New GROUNDBREAKING paper from Prof. Palti (TTF inventor) now provides incredible explanation. https://www.mdpi.com/1422-0067/26/24/12086
1 · Reply
scotofool
scotofool Jan. 2 at 2:55 PM
$NVCR mates, welcome 2026 year reckoning $NVCR conjob. Charlottan CEO bilked millions, tekkie don't work, data fudgy. Racket up, investors know user doccies no use. target 7.
1 · Reply
JuggernautRaider
JuggernautRaider Jan. 2 at 3:48 AM
$NVCR $JFBR $NUKK $KPTI all hit hard by targeted short selling due to Israel’s many issues and poised for better times ahead ⏰
0 · Reply
Tdorsey1776
Tdorsey1776 Jan. 1 at 12:36 AM
$NVCR Novocure to outperform the market in 2026.... time to look forward not back.
2 · Reply
GordonGecko_was_THE_MAN
GordonGecko_was_THE_MAN Dec. 29 at 10:47 PM
$NVCR seeing a bunch of clearly AI bot driven comments on this board of late. Perhaps this is a sign of more interest in NVCR? or maybe just ST has a problem with bots. are people seeing this on other boards as well?
1 · Reply
ConvergenceCharm
ConvergenceCharm Dec. 27 at 5:41 PM
$NVCR Market participants want evidence that strategy converts to numbers; cost controls have to translate into healthier margins — proving resilience would extend investor horizons. In the end, repeatable performance earns the premium.
1 · Reply
CapitalCallC
CapitalCallC Dec. 27 at 9:35 AM
$NVCR Risk tolerance remains selective and tied closely to execution credibility. Governance alignment can reduce perceived uncertainty. Transparency improvements could narrow valuation spreads. Ultimately, disciplined delivery will shape the outcome.
0 · Reply
GoBigRed19
GoBigRed19 Dec. 27 at 1:41 AM
0 · Reply
scotofool
scotofool Dec. 24 at 4:46 PM
to all the knowledge wankers pumping this turdy, piss off. yous not helping patient, $NVCR proper trash. datas overegged pudding. CEO muppet twit. target 7. merry xmas
0 · Reply
Latest News on NVCR
NovoCure Limited (NVCR) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 3:16 PM EDT - 2 months ago

NovoCure Limited (NVCR) Q3 2025 Earnings Call Transcript


Novocure Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 7:00 AM EDT - 2 months ago

Novocure Reports Third Quarter 2025 Financial Results


NovoCure: Buy Rating As Pipeline Gains Drive Renewed Momentum

Oct 17, 2025, 7:55 AM EDT - 2 months ago

NovoCure: Buy Rating As Pipeline Gains Drive Renewed Momentum


Novocure to Report Third Quarter 2025 Financial Results

Oct 1, 2025, 7:00 AM EDT - 3 months ago

Novocure to Report Third Quarter 2025 Financial Results


Novocure Announces Upcoming Investor Events

Aug 28, 2025, 7:00 AM EDT - 4 months ago

Novocure Announces Upcoming Investor Events


NovoCure's Wearable Oncology Edge And Compelling Valuation

Jul 30, 2025, 12:47 AM EDT - 5 months ago

NovoCure's Wearable Oncology Edge And Compelling Valuation


Top 3 Health Care Stocks That May Explode In July

Jul 28, 2025, 6:52 AM EDT - 5 months ago

Top 3 Health Care Stocks That May Explode In July

HCA MOH


NovoCure Limited (NVCR) Q2 2025 Earnings Call Transcript

Jul 25, 2025, 4:49 PM EDT - 5 months ago

NovoCure Limited (NVCR) Q2 2025 Earnings Call Transcript


Novocure Reports Second Quarter 2025 Financial Results

Jul 24, 2025, 7:00 AM EDT - 5 months ago

Novocure Reports Second Quarter 2025 Financial Results


Novocure to Report Second Quarter 2025 Financial Results

Jun 30, 2025, 7:00 AM EDT - 6 months ago

Novocure to Report Second Quarter 2025 Financial Results


NovoCure: Loading Up On Growth Catalysts

May 24, 2025, 3:12 AM EDT - 8 months ago

NovoCure: Loading Up On Growth Catalysts


NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 10:34 AM EDT - 9 months ago

NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript


Novocure Reports First Quarter 2025 Financial Results

Apr 24, 2025, 7:00 AM EDT - 9 months ago

Novocure Reports First Quarter 2025 Financial Results


Novocure to Report First Quarter 2025 Financial Results

Apr 1, 2025, 7:00 AM EDT - 9 months ago

Novocure to Report First Quarter 2025 Financial Results


NovoCure Q4 2024 Earnings: Strong And Growing Pipeline

Feb 28, 2025, 1:10 PM EST - 11 months ago

NovoCure Q4 2024 Earnings: Strong And Growing Pipeline


Novocure to Participate in Upcoming Investor Conferences

Nov 27, 2024, 7:00 AM EST - 1 year ago

Novocure to Participate in Upcoming Investor Conferences


Kyle7776
Kyle7776 Jan. 4 at 12:10 PM
$NVCR run to 20 or more with positive panova 4 data?
0 · Reply
GordonGecko_was_THE_MAN
GordonGecko_was_THE_MAN Jan. 3 at 8:35 PM
$NVCR (1/n) Science geeks: for a long time skeptics have asked exactly how TTFs work? Most who follow the story understand alternating fields re-orient the polar molecules required for the cell division, thus preventing proper division. However, we now have lots of data saying TTFs + IO is synergistic, that TTFs turn cold tumors hot. New GROUNDBREAKING paper from Prof. Palti (TTF inventor) now provides incredible explanation. https://www.mdpi.com/1422-0067/26/24/12086
1 · Reply
scotofool
scotofool Jan. 2 at 2:55 PM
$NVCR mates, welcome 2026 year reckoning $NVCR conjob. Charlottan CEO bilked millions, tekkie don't work, data fudgy. Racket up, investors know user doccies no use. target 7.
1 · Reply
JuggernautRaider
JuggernautRaider Jan. 2 at 3:48 AM
$NVCR $JFBR $NUKK $KPTI all hit hard by targeted short selling due to Israel’s many issues and poised for better times ahead ⏰
0 · Reply
Tdorsey1776
Tdorsey1776 Jan. 1 at 12:36 AM
$NVCR Novocure to outperform the market in 2026.... time to look forward not back.
2 · Reply
GordonGecko_was_THE_MAN
GordonGecko_was_THE_MAN Dec. 29 at 10:47 PM
$NVCR seeing a bunch of clearly AI bot driven comments on this board of late. Perhaps this is a sign of more interest in NVCR? or maybe just ST has a problem with bots. are people seeing this on other boards as well?
1 · Reply
ConvergenceCharm
ConvergenceCharm Dec. 27 at 5:41 PM
$NVCR Market participants want evidence that strategy converts to numbers; cost controls have to translate into healthier margins — proving resilience would extend investor horizons. In the end, repeatable performance earns the premium.
1 · Reply
CapitalCallC
CapitalCallC Dec. 27 at 9:35 AM
$NVCR Risk tolerance remains selective and tied closely to execution credibility. Governance alignment can reduce perceived uncertainty. Transparency improvements could narrow valuation spreads. Ultimately, disciplined delivery will shape the outcome.
0 · Reply
GoBigRed19
GoBigRed19 Dec. 27 at 1:41 AM
0 · Reply
scotofool
scotofool Dec. 24 at 4:46 PM
to all the knowledge wankers pumping this turdy, piss off. yous not helping patient, $NVCR proper trash. datas overegged pudding. CEO muppet twit. target 7. merry xmas
0 · Reply
Tdorsey1776
Tdorsey1776 Dec. 24 at 3:04 PM
$NVCR $VRDN $CAPR $TMDX Its a been a pretty excellent year in bio land, and there's much more to come in 2026 and beyond. Feeling especially appreciative; made a large contribution to St. Jude's. Please dont forget all they do for little kids who dont desrve to be stricken at such a young age and the familes living through the misery. Merry Christmas all.
1 · Reply
GeneticGains
GeneticGains Dec. 24 at 11:06 AM
$NVCR The longer-term setup revolves around whether timelines compress uncertainty rather than extend speculation. Sustained traction would support a meaningful re-rating.
1 · Reply
justiceforb_85
justiceforb_85 Dec. 23 at 4:47 AM
$NVCR when is the next update--FDA submission this quarter?
0 · Reply
CCrazy1990
CCrazy1990 Dec. 22 at 5:16 PM
$NVCR Question for the group: what would a positive PANOVA 4 data readout look like to you?
1 · Reply
DingDong9
DingDong9 Dec. 18 at 4:05 PM
$NVCR one of my top picks for 2026
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Dec. 18 at 12:59 PM
Brain-computer interface boom starting, most watch Neuralink — supply chain richer. Gold rush: shovel sellers. BCI "picks and shovels": $MDT: Medical devices $ABT: Neuro tech $SEM: Electrode materials $NVCR: Brain therapy $ISRG: Precision tools
0 · Reply
Czm514
Czm514 Dec. 16 at 3:25 PM
$NVCR Frank, how about a PR with some good news? Give those Israeli gangsters something to pump. Bag holders getting very weary. Down 57% YTD
1 · Reply
neilyoungsband
neilyoungsband Dec. 15 at 8:30 PM
$NVCR going under a dollar in 6 months....
1 · Reply
scotofool
scotofool Dec. 15 at 2:31 PM
$NVCR sure mate $NVCR 2026 boffins roasting noggins dead, proper trash, target 7
0 · Reply
Tdorsey1776
Tdorsey1776 Dec. 15 at 1:30 PM
$NVCR Its cold outside people, but feels like Novocure is getting ready to heat up in 2026. GLTA
0 · Reply
TommBa
TommBa Dec. 11 at 10:30 PM
$NWBO will it seems someone is worried about what is coming. Look who shows up for me on Google as a sponsored result when I searched for dcvax. Note: I am based in Spain at the moment, which is why $NVCR is showing .es
0 · Reply
scotofool
scotofool Dec. 11 at 4:41 PM
$NVCR @RudeYak wanker, price ridings markets, wait bottoms, looky history. trashy device, pisspoor leaders, falsified datas, proper cock-up. target 7
1 · Reply